Insider Selling: Axon Enterprise, Inc (NASDAQ:AXON) CAO Sells $57,885.75 in Stock

Axon Enterprise, Inc (NASDAQ:AXON) CAO Jennifer H. Mak sold 75 shares of the firm’s stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $771.81, for a total transaction of $57,885.75. Following the completion of the transaction, the chief accounting officer now directly owns 15,240 shares of the company’s stock, valued at approximately $11,762,384.40. This trade represents a 0.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Axon Enterprise Stock Down 0.9%

Shares of AXON opened at $770.79 on Thursday. Axon Enterprise, Inc has a 1 year low of $279.02 and a 1 year high of $806.64. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. The stock has a 50 day simple moving average of $683.57 and a two-hundred day simple moving average of $624.47. The firm has a market cap of $60.01 billion, a P/E ratio of 186.18, a P/E/G ratio of 89.50 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same period in the previous year, the business posted $1.15 EPS. The business’s quarterly revenue was up 31.3% on a year-over-year basis. On average, analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AXON has been the topic of a number of analyst reports. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Barclays upped their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Bank of America raised their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a “buy” rating in a report on Wednesday, June 4th. Finally, The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $699.55.

Institutional Trading of Axon Enterprise

Institutional investors have recently added to or reduced their stakes in the business. TCTC Holdings LLC increased its holdings in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after buying an additional 24 shares during the period. Fourth Dimension Wealth LLC bought a new position in Axon Enterprise during the 4th quarter worth approximately $30,000. Bartlett & CO. Wealth Management LLC increased its stake in Axon Enterprise by 132.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after purchasing an additional 33 shares during the period. Banque Transatlantique SA bought a new stake in Axon Enterprise in the first quarter valued at approximately $31,000. Finally, Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise in the first quarter valued at approximately $32,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.